861556-24-3 Usage
Uses
Used in Pharmaceutical Research:
2,3-dimethoxy-5-nitrobenzoic acid methyl ester is used as an intermediate compound for the synthesis of various pharmaceutical drugs. Its unique chemical structure allows it to be a key component in the development of new medications, particularly those targeting specific therapeutic areas.
Used in Organic Synthesis:
In the field of organic chemistry, 2,3-dimethoxy-5-nitrobenzoic acid methyl ester is employed as a building block for the creation of more complex organic compounds. Its reactivity and functional groups make it a valuable asset in the synthesis of a wide range of chemical products.
Used in Industrial Applications:
2,3-dimethoxy-5-nitrobenzoic acid methyl ester is used as a raw material in the production of certain organic compounds for industrial purposes. Its versatility in chemical reactions enables its use in the manufacturing of specialty chemicals, dyes, and other industrial products.
Check Digit Verification of cas no
The CAS Registry Mumber 861556-24-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,1,5,5 and 6 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 861556-24:
(8*8)+(7*6)+(6*1)+(5*5)+(4*5)+(3*6)+(2*2)+(1*4)=183
183 % 10 = 3
So 861556-24-3 is a valid CAS Registry Number.
861556-24-3Relevant academic research and scientific papers
IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE
-
Page/Page column 658, (2019/01/08)
Disclosed are compounds of formula (I), (II), (III), and (IV), and pharmaceutically acceptable salts thereof. The compounds are inhibitors of ALK2 kinase. Also provided are pharmaceutical compositions comprising a compound of formula (I), (II), (III), or (IV), or pharmaceutically acceptable salt thereof, and methods involving use of the compounds or pharmaceutically acceptable salts thereof and compositions in the treatment and prevention of various diseases and conditions, such as fibrodysplasia ossificans progressiva.
